{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:35:16Z","timestamp":1783226116817,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jacadv.2024.100927","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T11:22:13Z","timestamp":1712402533000},"page":"100927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers After Transcatheter Aortic Valve\u00a0Replacement"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-1550","authenticated-orcid":false,"given":"Vivek","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-1660","authenticated-orcid":false,"given":"Ankur","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.jacadv.2024.100927_bib1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","article-title":"Transcatheter aortic valve implantation versus surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis","volume":"40","author":"Siontis","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacadv.2024.100927_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/hrt.2010.192997","article-title":"Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis","volume":"97","author":"Cioffi","year":"2011","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.jacadv.2024.100927_bib3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehz769","article-title":"Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.jacadv.2024.100927_bib4","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2018.18077","article-title":"Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement","volume":"320","author":"Inohara","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jacadv.2024.100927_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/M13-1505","article-title":"Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study","volume":"161","author":"Goel","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacadv.2024.100927_bib6","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacadv.2024.100927_bib7","author":"Wells"},{"issue":"8","key":"10.1016\/j.jacadv.2024.100927_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/heartjnl-2017-311738","article-title":"Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation","volume":"104","author":"Ochiai","year":"2018","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.jacadv.2024.100927_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cjca.2020.08.014","article-title":"Dose-dependent effect of renin-angiotensin system blockade following transcatheter aortic valve replacement","volume":"37","author":"Ledwoch","year":"2021","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2024.100927_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.15171\/jcvtr.2019.30","article-title":"Renin-angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival","volume":"11","author":"Klinkhammer","year":"2019","journal-title":"J\u00a0Cardiovasc Thorac Res"},{"issue":"5","key":"10.1016\/j.jacadv.2024.100927_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacc.2019.05.055","article-title":"Renin-angiotensin system inhibition following transcatheter aortic valve replacement","volume":"74","author":"Rodriguez-Gabella","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacadv.2024.100927_bib12","first-page":"E662","article-title":"Acute kidney injury and renin-angiotensin system inhibition following transcatheter aortic valve replacement","volume":"33","author":"Phuong","year":"2021","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacadv.2024.100927_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjcard.2020.11.010","article-title":"Optimal medical therapy following transcatheter aortic valve implantation","volume":"141","author":"Kaewkes","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2024.100927_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2022.12.012","article-title":"Association of ACEI\/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): findings from real-world claims data","volume":"258","author":"Cubeddu","year":"2023","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.jacadv.2024.100927_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/ehjcvp\/pvac027","article-title":"Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation","volume":"8","author":"Fischer-Rasokat","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacadv.2024.100927_bib16","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 Consensus Document (VARC-2)","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"11","key":"10.1016\/j.jacadv.2024.100927_bib17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jacc.2013.03.060","article-title":"The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies","volume":"62","author":"Carroll","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jacadv.2024.100927_bib18","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical Research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2024.100927_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ehjci\/jew335","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"18","author":"Chair","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jacadv.2024.100927_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in Collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"4","key":"10.1016\/j.jacadv.2024.100927_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.echo.2019.01.003","volume":"32","author":"Zoghbi","year":"2019","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"7","key":"10.1016\/j.jacadv.2024.100927_bib22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacadv.2024.100927_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007451","article-title":"Progression of hypertrophy and myocardial fibrosis in aortic stenosis: a multicenter cardiac magnetic resonance study","volume":"11","author":"Everett","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"18","key":"10.1016\/j.jacadv.2024.100927_bib24","article-title":"Renin-angiotensin system blockade in aortic stenosis: implications before and after aortic valve replacement","volume":"9","author":"Goel","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2024.100927_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/16.suppl_O.107","article-title":"The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure","volume":"16 Suppl O","author":"Brilla","year":"1995","journal-title":"Eur Heart J"},{"issue":"9130","key":"10.1016\/j.jacadv.2024.100927_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(05)60717-9","article-title":"Aortic stenosis and ACE inhibitors","volume":"352","author":"Rimington","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2024.100927_bib27","article-title":"Netherlands Heart Registration Transcatheter Heart Valve Implantation Registration Committee. Survival and quality of life after transcatheter aortic valve implantation relative to the general population","volume":"28","author":"Zelis","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"6","key":"10.1016\/j.jacadv.2024.100927_bib28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jcin.2014.02.011","article-title":"Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations","volume":"7","author":"Lindman","year":"2014","journal-title":"J Am Coll Cardiol Intv"},{"issue":"9","key":"10.1016\/j.jacadv.2024.100927_bib29","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.amjcard.2019.08.004","article-title":"Meta-analysis for the use of renin-angiotensin inhibitors in post-TAVR patients","volume":"124","author":"Malik","year":"2019","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2024.100927_bib30","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.1002\/ccd.28899","article-title":"Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: a meta-analysis","volume":"97","author":"Sun","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jacadv.2024.100927_bib31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.21037\/apm-20-1155","article-title":"Impact of renin-angiotensin system blocker after aortic valve replacement-a systematic review and meta-analysis","volume":"10","author":"Zeng","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"5","key":"10.1016\/j.jacadv.2024.100927_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.recesp.2020.02.024","article-title":"Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis","volume":"74","author":"Amat-Santos","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"21","key":"10.1016\/j.jacadv.2024.100927_bib33","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jcin.2019.06.019","article-title":"Impact of pre-existing and new-onset atrial fibrillation on outcomes after transcatheter aortic valve replacement","volume":"12","author":"Mentias","year":"2019","journal-title":"J Am Coll Cardiol Intv"},{"issue":"23","key":"10.1016\/j.jacadv.2024.100927_bib34","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jcin.2017.09.010","article-title":"Incidence, prognostic impact, and predictive factors of readmission for heart failure after transcatheter aortic valve replacement","volume":"10","author":"Durand","year":"2017","journal-title":"J Am Coll Cardiol Intv"},{"issue":"2","key":"10.1016\/j.jacadv.2024.100927_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcin.2020.09.063","article-title":"Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement","volume":"14","author":"Sammour","year":"2021","journal-title":"J Am Coll Cardiol Intv"},{"issue":"15","key":"10.1016\/j.jacadv.2024.100927_bib36","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jacc.2013.01.047","article-title":"Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature","volume":"61","author":"Athappan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X2400111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X2400111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T05:47:49Z","timestamp":1716529669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X2400111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2772963X2400111X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.100927","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers After Transcatheter Aortic Valve\u00a0Replacement","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.100927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100927"}}